» Articles » PMID: 22705814

Problems of Stopping Trials Early

Overview
Journal BMJ
Specialty General Medicine
Date 2012 Jun 19
PMID 22705814
Citations 32
Authors
Affiliations
Soon will be listed here.
Citing Articles

Characteristics and Impact of Randomized Trials on Drugs or Devices in Cardiovascular Medicine.

Spagnolo M, Laudani C, Greco A, Giacoppo D, Capodanno D Am J Cardiovasc Drugs. 2024; 24(5):651-661.

PMID: 39088111 PMC: 11344709. DOI: 10.1007/s40256-024-00670-4.


Anticoagulation reversal (vitamin K, prothrombin complex concentrates, idarucizumab, andexanet-α, protamine).

Bekka E, Liakoni E Br J Clin Pharmacol. 2024; 91(3):604-614.

PMID: 38926082 PMC: 11862798. DOI: 10.1111/bcp.16142.


Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial.

Mancilla-Galindo J, Kammar-Garcia A, Mendoza-Gertrudis M, Garcia Acosta J, Nava Serrano Y, Santiago O Front Med (Lausanne). 2024; 10:1256197.

PMID: 38188344 PMC: 10766786. DOI: 10.3389/fmed.2023.1256197.


Point estimation for adaptive trial designs II: Practical considerations and guidance.

Robertson D, Choodari-Oskooei B, Dimairo M, Flight L, Pallmann P, Jaki T Stat Med. 2023; 42(14):2496-2520.

PMID: 37021359 PMC: 7614609. DOI: 10.1002/sim.9734.


Emerging Role of Sodium-Glucose Co-Transporter 2 Inhibitors for the Treatment of Chronic Kidney Disease.

Isidto R, Danguilan R, Naidas O, Vilanueva R, Arakama M, Paraiso L Int J Nephrol Renovasc Dis. 2023; 16:43-57.

PMID: 36852177 PMC: 9960786. DOI: 10.2147/IJNRD.S387262.